You are here

Drug Forecast

Rivaroxaban (Xarelto) for the Prevention of Thromboembolic Disease

An Inside Look at the Oral Direct Factor Xa Inhibitor
Younos Abdulsattar, PharmD Candidate, Rahul Bhambri, PharmD Candidate, and Anna Nogid, BS, PharmD, BCPS
PDF version: 
The authors review rivaroxaban (Xarelto), an anti-coagulant for preventing thromboembolic disease.